Propped against his motorcycle taxi outside a hospital in the city affected by Congo’s latest deadly Ebola outbreak, Jean Cedric waved a hand in the air, showing his fear about the risks of his job

Quick Read

Harvard social scientists have published controversial back-of-the-envelope estimates in the Journal of the American Medical Association (JAMA) of the possible toll from air and other pollutants

Quick Read

Global health officials say, ‘They did it all wrong’

Quick Read

Flinching as a gunshot whizzes past your window. Covering your ears when a police car races down your street, sirens blaring. Walking past a drug deal on your block or a beating at your school. For kids living in picket-fence suburbia, these experiences might be rare. But for their peers in urban poverty, they are all too commonplace

Quick Read

There are now several experimental treatments vying to be tested, but each must be greenlit by national regulatory authorities whenever and wherever an outbreak occurs. There remain deeply divergent positions among scientists about how to design outbreak trials, specifically whether studies that don’t compare treatments to placebos can generate useful data

Quick Read

China is making a bid to use its Ebola vaccine in the Democratic Republic of the Congo. It’s a move that could further complicate efforts to test a crowded field of vaccines and therapies in the context of a waning outbreak

Quick Read

The infection, an emerging threat, has killed virtually all of its victims so far in India

Quick Read

If we decide to use it. The debate over whether to use genetically modified mosquitoes to fight malaria, explained

Quick Read